Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.


Managing antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them?

In the latest episode of Drug Safety Matters, Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, tell podcast host Federica Santoro why they think it’s time the two communities joined forces for good.

Subscribe by visiting the Drug Safety Matters website or listen in right here:

You may also like


Underreporting in pharmacovigilance: Where do we go from here?

While underreporting remains a persistent global challenge, innovative approaches are showing promise in different regions

18 February 2026

Pharmacovigilance of a high-risk drug: Can AI save us?

An Australian research team is using artificial intelligence to improve the safe dosing of unfractionated heparin, a high-risk drug linked to serious side effects.

30 March 2026

Safe by perception, risky in practice? What vitamin B6 and turmeric teach us about complementary medicines

Complementary medicines are widely used and often perceived as safe, yet high doses, product stacking, and unclear labelling can quietly increase the risk of harm.

07 April 2026